{"id":408988,"date":"2021-01-05T16:18:30","date_gmt":"2021-01-05T21:18:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=408988"},"modified":"2021-01-05T16:18:30","modified_gmt":"2021-01-05T21:18:30","slug":"tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/","title":{"rendered":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences"},"content":{"rendered":"
\n

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Event<\/td>\nH.C. Wainwright BioConnect Conference<\/td>\n<\/tr>\n
Date<\/td>\nJanuary 11-14, 2021<\/td>\n<\/tr>\n
Time<\/td>\nPresentation available on demand January 11-14, 2021<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Event<\/td>\nBiotech Showcase 2021<\/td>\n<\/tr>\n
Date<\/td>\nJanuary 11-15, 2021<\/td>\n<\/tr>\n
Time<\/td>\nPresentation available on demand January 11-15, 2021<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Event<\/td>\nSidoti Winter Virtual Investor Conference\u00a0\u00a0<\/td>\n<\/tr>\n
Date<\/td>\nWednesday, January 13, 2021\u00a0\u00a0<\/td>\n<\/tr>\n
Time<\/td>\n9:15 a.m. ET\u00a0\u00a0<\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n
Event<\/td>\nICR Conference 2021\u00a0\u00a0<\/td>\n<\/tr>\n
Date<\/td>\nThursday, January 14, 2021\u00a0\u00a0<\/td>\n<\/tr>\n
Time<\/td>\n9:15 a.m. ET\u00a0\u00a0<\/td>\n<\/tr>\n<\/table>\n

Webcasts of the H.C. Wainwright, Sidoti and ICR conferences presentations will be available under the IR Events tab of the Investors section of the Tonix website at www.tonixpharma.com<\/u><\/a>.<\/p>\n

\n About Tonix Pharmaceuticals Holding Corp.<\/strong>\n <\/p>\n

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix\u2019s portfolio is primarily composed of central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix\u2019s lead CNS candidate, TNX-102 SL*, is in mid-Phase 3 development for the management of fibromyalgia since positive data on the RELIEF Phase 3 trial were recently reported. The Company expects topline data in the Phase 3 RALLY study in the fourth quarter of 2021.\u00a0 The immunology portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases. Tonix\u2019s lead vaccine candidate, TNX-1800**, is a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19, primarily by eliciting a T cell response. Tonix expects efficacy data from animal studies of TNX-1800 in the first quarter of 2021. TNX-801**, live horsepox virus vaccine for percutaneous administration, is in development to protect against smallpox and monkeypox.<\/p>\n

*TNX-102 SL is an investigational new drug and has not been approved for any indication.<\/p>\n

**TNX-1800 and TNX-801 are investigational new biologics and have not been approved for any indication.<\/p>\n

This press release and further information about Tonix can be found at www.tonixpharma.com<\/a>.<\/p>\n

Jessica Morris (corporate)
Tonix Pharmaceuticals
investor.relations@tonixpharma.com
<\/a>(862) 904-8182<\/p>\n

Olipriya Das, Ph.D. (media)
Russo Partners
Olipriya.Das@russopartnersllc.com<\/a>
(646) 942-5588<\/p>\n

Peter Vozzo (investors)
Westwicke, an ICR Company
peter.vozzo@westwicke.com<\/a>
(443) 213-0505<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January. Event H.C. Wainwright BioConnect Conference Date January 11-14, 2021 Time Presentation available on demand January 11-14, 2021 \u00a0 \u00a0 Event Biotech Showcase 2021 Date January 11-15, 2021 Time Presentation available on demand January 11-15, 2021 \u00a0 \u00a0 Event Sidoti Winter Virtual Investor Conference\u00a0\u00a0 Date Wednesday, January 13, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 \u00a0 \u00a0 Event ICR Conference 2021\u00a0\u00a0 Date Thursday, January 14, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 Webcasts of the H.C. Wainwright, Sidoti and ICR conferences … <\/p>\n

Continue reading “Tonix Pharmaceuticals to Participate in Upcoming January Conferences”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-408988","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January. Event H.C. Wainwright BioConnect Conference Date January 11-14, 2021 Time Presentation available on demand January 11-14, 2021 \u00a0 \u00a0 Event Biotech Showcase 2021 Date January 11-15, 2021 Time Presentation available on demand January 11-15, 2021 \u00a0 \u00a0 Event Sidoti Winter Virtual Investor Conference\u00a0\u00a0 Date Wednesday, January 13, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 \u00a0 \u00a0 Event ICR Conference 2021\u00a0\u00a0 Date Thursday, January 14, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 Webcasts of the H.C. Wainwright, Sidoti and ICR conferences … Continue reading "Tonix Pharmaceuticals to Participate in Upcoming January Conferences"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-05T21:18:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tonix Pharmaceuticals to Participate in Upcoming January Conferences\",\"datePublished\":\"2021-01-05T21:18:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/\"},\"wordCount\":397,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/\",\"name\":\"Tonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=\",\"datePublished\":\"2021-01-05T21:18:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tonix Pharmaceuticals to Participate in Upcoming January Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk","og_description":"CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will present at four upcoming virtual conferences in January. Event H.C. Wainwright BioConnect Conference Date January 11-14, 2021 Time Presentation available on demand January 11-14, 2021 \u00a0 \u00a0 Event Biotech Showcase 2021 Date January 11-15, 2021 Time Presentation available on demand January 11-15, 2021 \u00a0 \u00a0 Event Sidoti Winter Virtual Investor Conference\u00a0\u00a0 Date Wednesday, January 13, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 \u00a0 \u00a0 Event ICR Conference 2021\u00a0\u00a0 Date Thursday, January 14, 2021\u00a0\u00a0 Time 9:15 a.m. ET\u00a0\u00a0 Webcasts of the H.C. Wainwright, Sidoti and ICR conferences … Continue reading \"Tonix Pharmaceuticals to Participate in Upcoming January Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-05T21:18:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences","datePublished":"2021-01-05T21:18:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/"},"wordCount":397,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/","name":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=","datePublished":"2021-01-05T21:18:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMTAyOCMzOTA1ODE1IzIwMTExMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tonix-pharmaceuticals-to-participate-in-upcoming-january-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tonix Pharmaceuticals to Participate in Upcoming January Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=408988"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/408988\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=408988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=408988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=408988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}